MIXED MARTIAL ARTS GROUP (MMA) Grants Director 600,000 Performance Rights

Mixed Martial Arts Group Ltd director Taylor Vaughn William was granted 600,000 Performance Rights held indirectly via Nalaroo Holdings Pty Ltd. Each right converts into one ordinary share if MMA group revenue exceeds US$10,000,000 in any financial year ending on or before 30 June 2029. There is no service requirement; the rights vest immediately once the revenue condition is met and lapse entirely if it is not achieved by that date.

Confused Gary Coleman GIF

I’d be shocked if they made it until 2029 but I honestly have no clue what they actually do these day.

The last man standing at the old place was @marial_arts. They could have at least sent him a shirt.

2 Likes

Mixed @marialarts is deleted again ?. .

2 Likes

2 Likes

1 Like

Exactly

Exactly

1 Like

Nothing left….. :frowning:

2 Likes

Exclusive agreement gives MMA.INC direct participation in sales of U.S. manufactured, third party tested peptide recovery products across its global combat sports ecosystem

Highlights

  • MMA.INC enters high-growth peptide therapeutics and recovery market focused on the global martial arts community
  • Exclusive partnership with Precision Peptide Company Inc, a premium U.S.-manufactured peptide company listed on the CSE
  • MMA.INC to participate directly in revenue generated across its global customer base
  • Partnership provides MMA.INC a 50/50 share of MMA-generated net revenue in year 1 and 25% of net revenue for the remainder of the Term

Why MMA.INC is Expanding Into the High-Growth Recovery and Longevity Market

MMA.INC believes the partnership provides direct exposure to one of the fastest-growing categories across recovery optimization, regenerative medicine, preventative health, metabolic wellness, longevity and human performance.

The peptide sector has rapidly expanded in recent years as consumer demand for advanced recovery, performance optimization and wellness solutions has accelerated. At the same time, increasing regulatory scrutiny around manufacturing standards, product quality, labeling and commercialization practices is expected to accelerate a broader industry shift toward compliant, domestically manufactured and quality-controlled providers.

Historically, large portions of the peptide market have operated through fragmented offshore manufacturing and grey-market distribution channels with inconsistent quality standards. MMA.INC believes this industry transition creates a significant opportunity for premium operators capable of meeting higher compliance and manufacturing standards.

Precision’s products are manufactured in the United States and undergo third-party testing protocols designed to emphasize purity, consistency and quality assurance standards.

The partnership is strategically aligned with MMA.INC’s rapidly expanding combat sports participation ecosystem. Brazilian Jiu-Jitsu, mixed martial arts, wrestling, boxing and related disciplines place significant physical demands on participants, creating natural demand for advanced recovery, resilience and performance optimization solutions.

MMA.INC currently operates one of the world’s largest digitally connected combat sports ecosystems, with approximately 530,000 user profiles, more than 75,000 active students and over 800 verified gyms globally.

The Company believes this ecosystem creates a differentiated direct-to-consumer commercialization channel into one of the world’s most engaged athletic demographics, while further expanding MMA.INC’s broader strategy to build a vertically integrated participation platform spanning training, technology, recovery, wellness and performance optimization.

“This partnership establishes an entirely new commercial vertical for MMA.INC and positions the Company at the intersection of several major long-term growth trends, including recovery therapeutics, longevity, preventative health and regulated peptide commercialization,” said Nick Langton, Founder and CEO of MMA.INC.

“The peptide category is evolving rapidly, particularly as regulatory oversight increasingly shifts the market toward compliant, premium and U.S.-manufactured providers. Precision’s commitment to manufacturing quality, testing standards and compliance made them an extremely attractive strategic partner for MMA.INC.

“We believe our ecosystem provides a highly differentiated distribution channel into one of the world’s most engaged athletic communities, and the revenue-share structure allows MMA.INC to participate directly in the long-term commercial upside generated through that ecosystem.”

LOL

1 Like